RIO DE JANEIRO, BRAZIL - Researchers at Fiocruz (The Oswaldo Cruz Foundation, one of the world's leading public health research institutions) are betting on an initial vaccination against Covid-19 becoming available in February 2021 for a specific public. From then on, the domestic production of the doses may ensure immunization to the general population, says the Bio-Manguinhos (Fiocruz) vice-director of Quality, Rosane Cuber Guimarães.
Recent research results from . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here